TAGRISSO

astrazeneca canada inc🇨🇦 Health Canada

Approval Id: ec167147a43587cb
Drug Approval Canada Name: TAGRISSO
Product Name: TAGRISSO
Status: Marketed
Status Date: 2016-07-19
Original Market Date: 2016-07-19
Din: 02456222
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EB04 OSIMERTINIB
Atc Name: l 01 eb 04
Aig Number: 0158250002
Company Name: astrazeneca canada inc
Company Address: 1004 Middlegate Road, Suite 5000, Mississauga, Ontario, Canada, L4Y 1M4

OSIMERTINIB (OSIMERTINIB MESYLATE)

80 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ec167147a43587cb

Type

Standard